Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
2.18B
-
Number of holders
-
1159
-
Total 13F shares, excl. options
-
171M
-
Shares change
-
-9.34M
-
Total reported value, excl. options
-
$15.5B
-
Value change
-
-$839M
-
Put/Call ratio
-
0.49
-
Number of buys
-
403
-
Number of sells
-
-537
-
Price
-
$90.72
Significant Holders of NOVARTIS AG - Ordinary Shares (NVS) as of Q4 2022
1,259 filings reported holding NVS - NOVARTIS AG - Ordinary Shares as of Q4 2022.
NOVARTIS AG - Ordinary Shares (NVS) has 1,159 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 171M shares
of 2.18B outstanding shares and own 7.82% of the company stock.
Largest 10 shareholders include Dodge & Cox (20.8M shares), PRIMECAP MANAGEMENT CO/CA/ (17.2M shares), LOOMIS SAYLES & CO L P (10.9M shares), FRANKLIN RESOURCES INC (6.7M shares), MORGAN STANLEY (6.49M shares), BANK OF AMERICA CORP /DE/ (6.37M shares), DIMENSIONAL FUND ADVISORS LP (5.99M shares), WELLINGTON MANAGEMENT GROUP LLP (4.85M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (4.57M shares), and ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (4.13M shares).
This table shows the top 1159 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.